trending Market Intelligence /marketintelligence/en/news-insights/trending/sea0auxy1pr-tcicikyswq2 content esgSubNav
In This List

CytoDyn raises C$1M via securities offering

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


CytoDyn raises C$1M via securities offering

CytoDyn Inc. raised about C$1 million through a registered direct offering.

The Canadian developer of HIV treatments issued 1,970,000 shares at 50 Canadian cents each. Each stock will come bundled with a warrant to buy an additional stock for 75 cents apiece.

CytoDyn plans to use net proceeds, expected to be about C$900,000, on clinical trials for its lead product candidate and general corporate purposes.

Paulson Investment Co. LLC acted as placement agent for the offering.